Quantitative assessment of spironolactone treatment in women with diffuse androgen-dependent alopecia
1990; Society of Cosmetic Chemists; Volume: 42; Issue: 5 Linguagem: Inglês
ISSN
2689-5161
AutoresD. Hugh Rushton, Walter Futterweit, D. H. Kingsley, Philip J. Kingsley, M.J. NORRIS,
Tópico(s)melanin and skin pigmentation
Resumomonths with spironolactone (75 or 100 mg per day) and six remained untreated. In the untreated (control) group, mean values for total hair density (P 150 mg per day may be necessary to improve hair quality and increase hair density. However, further long-term studies are required to confirm these findings.
Referência(s)